Combinational silencing of components involved in JAK/STAT signaling pathway

Emira Bousoik1, Parvin Mahdipoor2, Abdulelah Alhazza2

  • 1Department of Biomedical and Pharmaceutical Sciences, Center for Targeted Drug Delivery, Harry and Diane Rinker Health Science Campus, Chapman University School of Pharmacy, 9401 Jeronimo Road, Irvine, CA 92618, United States; Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Derna, Derna, Libya.

Insights

Combinatorial gene silencing using small interfering RNA (siRNA) targeting JAK2 and gp 130 significantly enhanced RNA interference effects. This strategy shows promise for reducing cancer cell viability and migration in Triple Negative Breast Cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • The JAK/STAT pathway is crucial for cancer cell proliferation and survival.
  • Combinatorial silencing using small interfering RNA (siRNA) is an emerging strategy to enhance RNA interference efficacy.
  • Targeting multiple proteins within a pathway offers potential for improved therapeutic outcomes.

Purpose of the Study:

  • To investigate the efficacy of combinatorial siRNA silencing targeting the JAK/STAT pathway in Triple Negative Breast Cancer (TNBC) cells.
  • To evaluate the impact of targeting gp 130, JAK2, STAT3, and importin α3 individually and in combination.
  • To establish a proof-of-concept for enhanced RNA interference through combinatorial silencing.

Main Methods:

  • siRNA-mediated gene silencing was employed in two TNBC cell lines (MDA-MB-231 and MDA-MB-468).
  • Specific proteins targeted included gp 130, JAK2, STAT3, and importin α3.
  • Downstream effects on antiapoptotic, pro-apoptosis, and cell-cycle regulating proteins were analyzed.

Main Results:

  • Combinatorial silencing of JAK2 and gp 130 significantly enhanced RNA interference effects on downstream proteins.
  • This combination demonstrated a marked reduction in cell viability and migration.
  • The level of STAT3 activation was significantly reduced by the JAK2/gp 130 combinatorial silencing.

Conclusions:

  • Simultaneous targeting of JAK2 and gp 130 via siRNA is a promising combinatorial silencing strategy.
  • This approach shows potential for enhancing cancer treatment efficacy by modulating key signaling pathways.
  • The findings support the development of combinatorial RNA interference strategies for cancer therapy.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
10.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K